← Open Payments lookup

MIGUEL FONSECA-MORENO: Open Payments

NPI 1417724402 · ANTHEM, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$299 in 14 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $299

Food & beverage: $299
CompanyPaymentsAmount
Almatica Pharma LLC2$54
Otsuka America Pharmaceutical, Inc.2$51
Boston Scientific Corporation1$36
Lundbeck LLC2$34
Sumitomo Pharma America, Inc.1$29
AstraZeneca Pharmaceuticals LP1$19
Aimmune Therapeutics, Inc.1$19
Novo Nordisk Inc1$15
Lilly USA, LLC1$15
Neurocrine BioSciences, Inc.1$15

Products named: REXULTI, TERIPARATIDE, General - Therapies, GEMTESA, BREZTRI, ZENPEP, Ozempic, KISUNLA.

Industry payments across AZ — which companies pay providers there.